Literature DB >> 2765903

Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway.

P R Hof1, C Bouras, J Constantinidis, J H Morrison.   

Abstract

Previous quantitative neuropathologic analyses have shown that the association cortices of the temporal and frontal lobes are more damaged than the visual regions of the occipital lobe in Alzheimer's disease. In the present paper, we report on a subpopulation of Alzheimer's disease patients presenting a visual defect referred to as Balint's syndrome, and displaying a global caudal shift in pathology. Balint's syndrome is a defect in visuospatial skills, and the distribution of pathology suggests that the connections underlying this functional component of the visual system are devastated, whereas they are normally spared in Alzheimer's disease. These results suggest that multiple subtypes of Alzheimer's disease exist with differential distribution of pathology and corresponding neurologic symptomatology, and that neuritic plaque and neurofibrillary tangle formation involve the loss of specific corticocortical projections associated with specific functional deficits and identifiable neurologic syndromes.

Entities:  

Mesh:

Year:  1989        PMID: 2765903     DOI: 10.1016/0006-8993(89)91173-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  39 in total

Review 1.  Binding, spatial attention and perceptual awareness.

Authors:  Lynn C Robertson
Journal:  Nat Rev Neurosci       Date:  2003-02       Impact factor: 34.870

2.  A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  P G Vallet; R Guntern; P R Hof; J Golaz; A Delacourte; N K Robakis; C Bouras
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease.

Authors:  R Guntern; C Bouras; P R Hof; P G Vallet
Journal:  Experientia       Date:  1992-01-15

4.  Imaging correlates of posterior cortical atrophy.

Authors:  Jennifer L Whitwell; Clifford R Jack; Kejal Kantarci; Stephen D Weigand; Bradley F Boeve; David S Knopman; Daniel A Drubach; David F Tang-Wai; Ronald C Petersen; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2006-06-23       Impact factor: 4.673

5.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

6.  Approach to atypical Alzheimer's disease and case studies of the major subtypes.

Authors:  Bradford C Dickerson; Scott M McGinnis; Chenjie Xia; Bruce H Price; Alireza Atri; Melissa E Murray; Mario F Mendez; David A Wolk
Journal:  CNS Spectr       Date:  2017-02-15       Impact factor: 3.790

7.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.

Authors:  Melissa E Murray; Neill R Graff-Radford; Owen A Ross; Ronald C Petersen; Ranjan Duara; Dennis W Dickson
Journal:  Lancet Neurol       Date:  2011-07-27       Impact factor: 44.182

8.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease.

Authors:  Chenjie Xia; Sara J Makaretz; Christina Caso; Scott McGinnis; Stephen N Gomperts; Jorge Sepulcre; Teresa Gomez-Isla; Bradley T Hyman; Aaron Schultz; Neil Vasdev; Keith A Johnson; Bradford C Dickerson
Journal:  JAMA Neurol       Date:  2017-04-01       Impact factor: 18.302

9.  Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease.

Authors:  D C Davies; P McCoubrie; B McDonald; K A Jobst
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

10.  Alzheimer's disease in a patient with posterior cortical atrophy.

Authors:  M L Berthier; R Leiguarda; S E Starkstein; G Sevlever; A L Taratuto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.